Revive Therapeutics Ltd. (RVV.CN)
CAD 0.01
(-50.0%)
CAD 0.01
(-50.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 CAD | 20.43% |
| 2022 | -0.02 CAD | 66.67% |
| 2021 | -0.06 CAD | 26.09% |
| 2020 | -0.08 CAD | -89.22% |
| 2019 | -0.04 CAD | -86.45% |
| 2018 | -0.02 CAD | 28.9% |
| 2017 | -0.03 CAD | 11.21% |
| 2016 | -0.03 CAD | 69.18% |
| 2015 | -0.11 CAD | -16.77% |
| 2014 | -0.09 CAD | -52.92% |
| 2013 | -0.06 CAD | -275.61% |
| 2012 | -0.02 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q3 | -0.00 CAD | -118.18% |
| 2023 Q4 | -0.01 CAD | -29.17% |
| 2023 Q1 | -0.00 CAD | 66.67% |
| 2023 Q2 | -0.00 CAD | -100.0% |
| 2022 Q2 | -0.00 CAD | 9.62% |
| 2022 Q1 | -0.01 CAD | 40.91% |
| 2022 FY | - CAD | 66.67% |
| 2022 Q4 | -0.00 CAD | 44.07% |
| 2022 Q3 | -0.01 CAD | -25.53% |
| 2021 FY | - CAD | 26.09% |
| 2021 Q2 | -0.01 CAD | 15.69% |
| 2021 Q3 | -0.02 CAD | -46.51% |
| 2021 Q4 | -0.01 CAD | 53.44% |
| 2021 Q1 | -0.02 CAD | 44.96% |
| 2020 Q2 | -0.01 CAD | 43.96% |
| 2020 Q3 | -0.01 CAD | -44.12% |
| 2020 Q4 | -0.03 CAD | -89.12% |
| 2020 FY | - CAD | -89.22% |
| 2020 Q1 | -0.02 CAD | -31.88% |
| 2019 Q3 | -0.02 CAD | -229.41% |
| 2019 Q2 | -0.01 CAD | -18.6% |
| 2019 Q4 | -0.01 CAD | 17.86% |
| 2019 Q1 | -0.00 CAD | 32.81% |
| 2019 FY | - CAD | -86.45% |
| 2018 FY | - CAD | 28.9% |
| 2018 Q4 | -0.01 CAD | -68.42% |
| 2018 Q3 | -0.00 CAD | 30.91% |
| 2018 Q2 | -0.01 CAD | -5.77% |
| 2018 Q1 | -0.01 CAD | 41.57% |
| 2017 Q3 | -0.01 CAD | 11.39% |
| 2017 Q4 | -0.01 CAD | -27.14% |
| 2017 FY | - CAD | 11.21% |
| 2017 Q2 | -0.01 CAD | 3.66% |
| 2017 Q1 | -0.01 CAD | 17.17% |
| 2016 Q1 | -0.01 CAD | 30.53% |
| 2016 FY | - CAD | 69.18% |
| 2016 Q4 | -0.01 CAD | -10.0% |
| 2016 Q3 | -0.01 CAD | -57.89% |
| 2016 Q2 | -0.01 CAD | 37.36% |
| 2015 Q3 | -0.02 CAD | 38.94% |
| 2015 Q2 | -0.03 CAD | 11.02% |
| 2015 FY | - CAD | -16.77% |
| 2015 Q1 | -0.04 CAD | -94.39% |
| 2015 Q4 | -0.01 CAD | 36.71% |
| 2014 Q4 | -0.02 CAD | -3.7% |
| 2014 Q3 | -0.02 CAD | -2.72% |
| 2014 Q2 | -0.02 CAD | -10.18% |
| 2014 Q1 | -0.02 CAD | 65.5% |
| 2014 FY | - CAD | -52.92% |
| 2013 Q2 | -0.03 CAD | 43.87% |
| 2013 Q3 | -0.01 CAD | 65.19% |
| 2013 Q4 | -0.05 CAD | -310.17% |
| 2013 Q1 | -0.06 CAD | -1489.47% |
| 2013 FY | - CAD | -275.61% |
| 2012 Q2 | -0.01 CAD | -700.0% |
| 2012 Q1 | -0.00 CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | -0.00 CAD | 57.14% |
| 2012 Q4 | -0.00 CAD | -58.33% |
| 2011 Q4 | - CAD | 0.0% |